Comparison of neutralization activity against Omicron BA.2/BA.5 in sera from HCWs receiving heterologous/homologous COVID-19 vaccines
Author:
Funder
National Center for Global Health and Medicine
National Institutes of Health
National Cancer Institute
Japan Agency for Medical Research and Development
Publisher
Elsevier BV
Subject
Infectious Diseases,Microbiology (medical)
Reference6 articles.
1. Longitudinal age differences in humoral responses to the COVID-19 vaccine in the elderly are lost after the third dose;Pozo-Balado;J Infect,2022
2. Restoration of neutralization activity against Omicrons BA.2 and BA.5 in older adults and individuals with risk factors following the 4th-dose of SARS-CoV-2 BNT162b2 vaccine;Amano;J Infect Dis,2022
3. Correlates of neutralizing/SARS-CoV-2-S1- binding antibody response with adverse effects and immune kinetics in BNT162b2- vaccinated individuals;Maeda;Sci Rep,2021
4. Third-dose BNT162b2 vaccination elicits markedly high-level SARS-CoV-2-neutralizing antibodies in vaccinees who poorly responded to second dose in Japan;Amano;J Infect Dis,2022
5. Neutralization activity of Sera/IgG Preparations from fully BNT162b2 vaccinated individuals against SARS-CoV-2 Alpha Beta Gamma Delta and Kappa variants;Amano;Sci Rep,2022
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Neutralization activity of HCWs’ sera after Omicron XBB.1.5-adapted monovalent COVID-19 mRNA vaccination;Journal of Infection;2024-07
2. Longitudinal analysis of neutralization in sera from HCWs receiving 2 doses of Omicron BA.4/5-adapted bivalent vaccine;Journal of Infection;2023-11
3. Neutralization against Omicron sublineages (BA.2/BA.5/BQ.1.1/XBB/XBB.1.5) in bivalent BNT162b2-vaccinated HCWs with or without risk factors, or following BT infection with Omicron;Scientific Reports;2023-10-13
4. Neutralization against Omicron sublineages (BA.2/BA.5/BQ.1.1/XBB/XBB.1.5) in bivalent BNT162b2-vaccinated HCWs with or without risk factors, or following BT infection with Omicron;2023-08-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3